2021
DOI: 10.1016/j.annonc.2021.08.445
|View full text |Cite
|
Sign up to set email alerts
|

164P Effect of ELOVL5 expression on breast cancer development

Abstract: Conclusions: To our knowledge, this is one of the largest studies of young breast cancer patients in Africa comparing the local failure after mastectomy and BCS. In this large study, breast-conserving surgery was not detrimental to locoregional control in young African breast cancer patients and should be considered whenever feasible and discussed with patients for a joint decision.Legal entity responsible for the study: The authors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
1
0
Order By: Relevance
“…It is known that its expression in breast cancer cells is elevated and that it directly affects the lipid composition in serum (Tomida et al, 2021). Moreover, the complete knockout of ELOVL5 in the mouse breast carcinoma model led to a delay in tumor development and a decrease in tumor growth (Kieu et al, 2021). At the same time, the data on the impact of the IGFBP6 gene on the lipid metabolism are limited.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that its expression in breast cancer cells is elevated and that it directly affects the lipid composition in serum (Tomida et al, 2021). Moreover, the complete knockout of ELOVL5 in the mouse breast carcinoma model led to a delay in tumor development and a decrease in tumor growth (Kieu et al, 2021). At the same time, the data on the impact of the IGFBP6 gene on the lipid metabolism are limited.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, ELOVL5 is highly expressed in the central nervous system and mutations in the gene were found to be the cause of spinocerebellar ataxia type 38 (SCA38), a rare autosomal neurological disease characterized by gait abnormality, dysarthria, dysphagia, hyposmia, and peripheral neuropathy (Balbo et al, 2021). While reduction in ELOVL5 expression has been linked to worsened prognosis in breast estrogen receptor-positive cancer patients (Kieu et al, 2022), its role in behavior regulation is still unclear. The observed increased expression of ELOVL5 and FADS2 in Sub mice, together with the elevation of the parental DA and EPA levels, as well as with DEA and related metabolites, suggest that the signaling pathways mediated by these molecules are of importance for social behavior and personality manifestations.…”
Section: Discussionmentioning
confidence: 99%